MedTrace Logo

Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient

NCT01443013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 266

Last updated 2015-10-20

No results posted yet for this study

Summary

This observational study is designed to analyse the urinary mRNA expression of Foxp3 and Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant recipients from 17 renal transplant site in France and to determine the predictive value of these gene expression on the one year graft outcome including graft function, one-year graft histological analysis and incidence of acute rejection.

Conditions

  • Function of Renal Transplant

Interventions

OTHER

Renal Transplant

urinary sample at month 3, 6 and 12

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Philippe Grimbert, MD PHD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01443013 on ClinicalTrials.gov